SSI INVESTMENT MANAGEMENT LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SSI INVESTMENT MANAGEMENT LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$8,464,220
-8.2%
8,726,000
-7.0%
0.69%
+7.0%
Q2 2023$9,219,566
-35.9%
9,386,000
-33.0%
0.65%
-35.9%
Q1 2023$14,383,199
-2.7%
14,019,000
+0.7%
1.01%
+7.8%
Q4 2022$14,780,730
+4.6%
13,927,000
-2.3%
0.94%
-1.3%
Q3 2022$14,128,000
+20.1%
14,257,000
+20.0%
0.95%
+28.4%
Q2 2022$11,761,000
+29.7%
11,878,000
+30.9%
0.74%
+49.3%
Q1 2022$9,068,000
-3.0%
9,071,000
+1.4%
0.50%
-9.7%
Q4 2021$9,351,000
+1987.3%
8,944,000
+1914.4%
0.55%
+1612.5%
Q1 2021$448,000
-19.9%
444,000
-14.9%
0.03%
-20.0%
Q4 2020$559,000
-92.1%
522,000
-92.3%
0.04%
-93.5%
Q3 2020$7,079,000
-45.8%
6,747,000
-36.9%
0.61%
-46.6%
Q2 2020$13,070,000
+85.2%
10,695,000
+57.7%
1.14%
+84.1%
Q1 2020$7,058,000
-11.0%
6,781,000
-9.7%
0.62%
+17.8%
Q4 2019$7,932,000
+14.7%
7,511,000
+6.8%
0.53%
+5.0%
Q3 2019$6,915,000
-6.6%
7,035,000
-1.4%
0.50%
-8.5%
Q2 2019$7,407,000
+17.1%
7,135,000
+15.4%
0.55%
+3.8%
Q1 2019$6,328,000
+1.9%
6,185,000
-1.0%
0.53%
-8.8%
Q4 2018$6,210,000
-3.3%
6,245,000
+2.7%
0.58%
+17.4%
Q3 2018$6,421,0006,083,0000.50%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 19,413,000$19,245,6111.50%
SSI INVESTMENT MANAGEMENT LLC 9,386,000$9,219,5660.65%
PFM Health Sciences, LP 15,000,000$14,771,5200.57%
RWC Asset Management LLP 11,000,000$10,848,4750.52%
Sonora Investment Management Group, LLC 6,280,000$6,184,8580.52%
ADVENT CAPITAL MANAGEMENT /DE/ 24,020,000$23,654,1280.46%
Lombard Odier Asset Management (Europe) Ltd 7,224,000$7,124,4890.34%
MACKAY SHIELDS LLC 10,123,000$9,943,5200.28%
PALISADE CAPITAL MANAGEMENT, LP 9,478,000$9,323,9830.25%
Nicholas Investment Partners, LP 2,940,000$2,887,8680.20%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders